Effects of phosphodiesterase inhibitors on hypoxic pulmonary vasoconstriction. Influence of K + channels and nitric oxide

Author： Goirand F.   Bardou M.   Dumas J.-P.   Rochette L.   Dumas M.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.417, Iss.1, 2001-04, pp. : 141-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effect of the nitric oxide synthase inhibitor N- -nitro-l-argine methyl ester on hypoxic pulmonary vasoconstriction

By Jones R.D.   Morice A.H.  

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 111-117

Elsevier

Access to resources Recommend Favorite

Regulation of Inducible Nitric Oxide Synthase by cAMP-Elevating Phosphodiesterase Inhibitors

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 1, 2003-01 ,pp. : 63-79

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear factor- B inhibitors abolish hypoxic vasoconstriction in sheep-isolated pulmonary arteries

By Uzun O.   Demiryurek A.T.  

European Journal of Pharmacology, Vol. 458, Iss. 1, 2003-01 ,pp. : 171-174

Elsevier

Access to resources Recommend Favorite

Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat

By Valentin J.-P.   Bessac A.-M.   Maffre M.   John G.W.  

European Journal of Pharmacology, Vol. 317, Iss. 2, 1996-12 ,pp. : 335-342

Elsevier

Access to resources Recommend Favorite

Hypoxic pulmonary vasoconstriction - Regulation in human pulmonary vascular smooth muscle cells

By Dumas J.P.   Bardou M.   Goirand F.   Dumas M.  

General Pharmacology, Vol. 33, Iss. 4, 1999-10 ,pp. : 289-297

Elsevier

Access to resources Recommend Favorite